WHO Chief Scientist Somaya Swaminathan said on Sunday that the World Health Organization (WHO) Technical Advisory Group will meet on October 26 to consider the Emergency Use List (EUL) for the Covid-19 vaccine from Bharat Biotech, Covaxin.

“The Technical Advisory Group will meet on October 26 to consider an end user license agreement for #Covaxin. WHO is working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad range of vaccines approved for emergency use and expand access to populations everywhere,” said Swaminathan. in a tweet.

Read also | WHO’s nod about Covaxin may take “a few more weeks” during technical inquiries; Routine, says HealthBody

The Emergency Use List (EUL) is a procedure to simplify the process by which new or unlicensed products can be used during public health emergencies, according to WHO guidelines. Swaminathan had earlier said that all countries should recognize EUL vaccines.

The approval of a vaccine made in India is much awaited, especially by students, medical tourists, business travelers and people with international travel plans. It has been in the pipeline since July.

Bharat Biotech submitted all the required documents for the End User License Agreement on July 9. “All documents required for the EUL for Covaxin have been submitted to the World Health Organization as of July 9. The review process has now begun with the expectation that we will receive an End User License Agreement from WHO. Dr. Krishna Ella, Chairman and Managing Director, said Dr. Krishna Ella, Chairman and Managing Director of Bharat Biotech, in a statement.

That statement was issued, in July, days after Suchitra Ella, the company’s co-founder and joint general manager, said approval from the WHO was not expected to be a “prolonged process”.

“We are working closely with the World Health Organization to include Covaxin in the list of emergency uses. Approval from WHO is not expected to be a lengthy process as the cell line and the majority of our facilities have already been audited and approved by the WHO for our other vaccines in the past,” Suchitra Ella wrote on Twitter.

Read all the latest news, breaking news and coronavirus news here. Follow us Facebook social networking siteAnd Twitter And cable.

Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *